☆ 4.7 Article

Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Review Cardiac & Cardiovascular Systems

Percutaneous transluminal septal myocardial ablation: past, present, and future

Yuichiro Maekawa et al.

Summary: Approximately 30% of patients with hypertrophic cardiomyopathy have a significant left ventricular pressure gradient, with the majority diagnosed as hypertrophic obstructive cardiomyopathy. Percutaneous transluminal septal myocardial ablation has been introduced as a method to reduce this gradient and improve heart failure symptoms. However, the outcome is influenced by operators' experience and it is difficult to predict the response in advance. Advances in imaging modalities have helped in understanding the mechanisms of left ventricular outflow tract obstruction and will aid in better treatment selection.

JOURNAL OF CARDIOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy

Jae-Man Lee et al.

Summary: This study evaluated the ability of a scoring system based on cardiopulmonary exercise testing (CPET) to predict cardio-cerebral events in patients with hypertrophic cardiomyopathy (HCM). The results showed that the novel scoring model using left atrial volume index (LAVI) had the highest predictive power among the models.

PLOS ONE (2022)

Add to Collection

Article Multidisciplinary Sciences

Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation

Takenori Ikoma et al.

Summary: Age, female sex, dilated cardiomyopathy, hypertrophic cardiomyopathy, persistent AF and larger LA volume may predict the presence of low-voltage zones.

PLOS ONE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy

Toru Kubo et al.

Summary: This study aimed to investigate the prevalence and prognostic impact of atrial fibrillation (AF), particularly new-onset AF, in Japanese patients with hypertrophic cardiomyopathy (HCM). The presence of AF, especially new-onset AF, was associated with an increased risk of HCM-related adverse events, particularly heart failure events. AF may not only be a marker of disease stage but also an important trigger of adverse events in patients with HCM.

ESC HEART FAILURE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies

Hiroaki Kitaoka et al.

CIRCULATION JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy

Toru Kubo et al.

Summary: This study conducted a detailed investigation on Japanese patients with HCM and found a high prevalence of AF in the elderly community, with AF, especially new-onset AF, associated with an increased incidence of HCM-related events. AF may not just be an indicator of disease stage but also a significant trigger for adverse events in patients with HCM.

ESC HEART FAILURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction Insights From the SHaRe Registry

Peter Marstrand et al.

CIRCULATION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy

Yishay Wasserstrum et al.

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis

Josef Veselka et al.

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes

Carey Kimmelstiel et al.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)

Add to Collection

Article Medicine, Research & Experimental

Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy

Yoshiyasu Aizawa et al.

KEIO JOURNAL OF MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Patients' Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study

Toru Kubo et al.

CIRCULATION JOURNAL (2018)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance

Yasuo Amano et al.

MAGNETIC RESONANCE IN MEDICAL SCIENCES (2018)

Add to Collection

Review Medicine, General & Internal

Clinical Course and Management of Hypertrophic Cardiomyopathy

Barry J. Maron

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Multidisciplinary Sciences

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?

Kyoung-min Park et al.

PLOS ONE (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Patterns of Disease Progression in Hypertrophic Cardiomyopathy An Individualized Approach to Clinical Staging

Iacopo Olivotto et al.

CIRCULATION-HEART FAILURE (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Bernard J. Gersh et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Add to Collection

Article Cardiac & Cardiovascular Systems

Dilated-hypokinetic evolution of hypertrophic cardiomyopathy - Prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients

E Biagini et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)

Add to Collection

Article Urology & Nephrology

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

AS Levey et al.

KIDNEY INTERNATIONAL (2005)

Add to Collection

Article Cardiac & Cardiovascular Systems

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients

L Monserrat et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.